Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimising Cardiovascular Health in Endometrial Cancer Survivors

NCT05216913 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.

NCT NCT05216913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05216913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimising Cardiovascular Health in Endometrial Cancer Survivors
Lead sponsor
University of Manchester
Phase
Observational
Overall status
Unknown status
Start date
February 9, 2022
Completion date
October 31, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, endometrial cancer